Symposium

Symposium Schedule Optional programs to enrich your meeting experience

All Urologists & APP-Allied Health Pros Invited.

---

Saturday, October 24 11:15 am – 12:30 pm NON CME SYMPOSIUM – Erleada: TITAN and New Data for SPARTAN Final Analysis. Symposium SYMPOSIA

• Christopher P. Evans, MD (Speaker) Professor & Chair, Dpt. of Urologic Surgery, UC Davis

Supported by Janssen Biotech, Inc.

---

Sunday, October 25 8:00 am – 9:00 am CME/CE SYMPOSIUM – Improving Outcomes in OAB: Emerging Strategies to Reduce Symptom Burden and Treatment Adverse Effects Symposium SYMPOSIA

• Kathleen Kobashi, MD (Speaker) Virginia Mason Med. Ctr.
• Roger Dmochowski, MD (Speaker) Vanderbilt University Medical Center VUMC

Activity Description

Overactive bladder (OAB) is a common condition that can significantly impair quality of life and carries a substantial personal and societal economic burden. Available evidence indicates that OAB is undertreated and inappropri…

See More

---

Monday, October 26 8:00 am – 9:00 am NON CME SYMPOSIUM – New Data and Therapies for Advanced Prostate Cancer: What Is Optimal Care? Symposium SYMPOSIA

• Neal Shore, MD (Speaker) Medical Director, Carolina Urologic Research Center

Supported by Tolmar

---

Monday, October 26

3:45 pm – 4:45 pm

NON CME SYMPOSIUM – Important Evidence-Based Changes in the Metastatic Castration-Sensitive Prostate Cancer Treatment Landscape. Symposium SYMPOSIA

• William Aronson, MD (Speaker) Professor, UCLA Department of Urology

 Supported by Astellas Pharma US / Pfizer Oncology

---

Tuesday, October 27 7:45 am – 9:00 am NON CME SYMPOSIUM – Commercial Genomic Assays for Localized Prostate Cancer: How Do They Compare? Symposium SYMPOSIA

• Robert Reiter, MD (Speaker) UCLA

Supported by Exact Sciences

---

Tuesday, October 27 3:15 pm – 4:15 pm NON CME SYMPOSIUM – Androgen Deprivation Therapy (ADT): Reducing Morbidity and Improving Outcome. Symposium SYMPOSIA

• Laurence Klotz, MD, (Speaker) Professor of Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Supported by Abbvie

 

---

Wednesday, October 28 2:15 pm – 3:15 pm NON CME SYMPOSIUM – A Treatment Approach for Certain Patients with High-Risk Non-Muscle Invasive Bladder Cancer. Symposium SYMPOSIA

• Bryan Mehlhaff, MD (Speaker)

Supported by Merck

Learning Objectives:

• Review the features of NMIBC
• Evaluate the clinical data on a treatment option for certain patients with high-risk NMIBC
• Understand the safety data associated with this treatment option for certain pa…

See More